Why Doesn't Magnesium Work? The Real Reasons Explained

Aug 26, 2026 · 8 min · magnesium doesn't work

Dr Cath

Chemistry PhD · evidence-based supplementation

Why Doesn't Magnesium Work? The Real Reasons Explained

Why didn't the magnesium do anything?

When someone tells me magnesium "didn't work," the most likely explanation is not the brand, the form, or the dose. It is that there was no deficit to correct, and magnesium's demonstrated usefulness is largely the usefulness of correcting a deficit. Four explanations cover almost every case:

You were not short of magnesium. Repletion only produces a visible change if something was depleted.
The symptom you targeted is not magnesium-responsive. Fatigue, low mood and poor sleep have many causes, and most of them are not mineral status.
Very little of the dose was absorbed. Poorly soluble compounds pass through with a substantial fraction unabsorbed.
You judged it on the wrong endpoint. A blood test that stays inside the reference range tells you almost nothing about tissue stores.

Only the third of those is a product problem. That is worth knowing before you buy a more expensive form.

What would "working" even look like?

This is where most disappointment starts. Four different things get labelled as magnesium working, and they sit on completely different evidence levels.

Chemistry: the compound dissolves and releases magnesium ions. Established, and trivially true for the soluble forms.
Exposure: your intake goes up and, if you were depleted, serum magnesium rises. That is a biomarker, not a benefit.
Intermediate outcome: blood pressure, glucose handling, sleep-onset latency, cramp frequency.
Clinically meaningful outcome: fewer events, a diagnosis resolved, a symptom you would actually notice.

Supplement marketing routinely presents level one and level two as though they were levels three and four. A capsule that raises your intake has done its chemical job even when you feel identical afterwards.

There is a physiological trap here too. Most body magnesium sits in bone and inside cells; the fraction circulating in serum is small and tightly regulated. A serum value inside the reference range is therefore compatible with depleted stores, and a rising serum value after supplementation is not proof that anything functionally important changed. That is a mechanistic argument about compartments, not trial evidence — but it does mean you cannot cheaply verify your own status, which makes self-assessment of "did it work" unreliable.

Who is actually likely to notice something?

The honest framing is not "magnesium may help with X" but "magnesium may help people who are losing or under-consuming it, and probably not otherwise." Plausible candidates for a real deficit include people with persistently low dietary intake, chronic alcohol use, prolonged gastrointestinal losses, and those on medications that increase renal or intestinal magnesium loss — proton pump inhibitors and certain diuretics among them. Depletion in these settings is a recognised clinical phenomenon; whether supplementing changes any given symptom in any given person is a separate question.

Much of the published health-outcome literature on magnesium is associative rather than interventional, and that distinction decides what you can conclude. A correlational analysis in Rural Remote Health reported that low magnesium may relate to higher rates of type 2 diabetes in Indigenous Australians — the paper's own framing is that correlations suggest this. Correlations between a population's magnesium status and its disease rates cannot establish that supplementation prevents the disease, and the finding is specific to the population studied.

The same logic applies to mood. A study in Psychology Research and Behavior Management reported an association between serum magnesium levels and depression in patients undergoing peritoneal dialysis. That is an association measured in a single clinical population with substantially altered mineral handling. It does not show that magnesium supplementation improves depressive symptoms, and nothing in it extends to a healthy adult buying a bottle for low mood.

So: established for correcting documented deficiency; plausible to unresolved for symptom relief in people whose magnesium status is normal.

What are the drawbacks and limits?

Magnesium is cheap and generally well tolerated, which encourages open-ended use. The real limits are these:

Osmotic and laxative effect. Poorly absorbed magnesium compounds retain water in the gut. This is dose-dependent, predictable, and the reason some magnesium preparations are used deliberately as laxatives. It is not a sign of "detoxing."
Reduced kidney function changes the calculus. The kidney is the main route of magnesium excretion. Anyone with impaired renal function should treat magnesium supplementation as a medical decision, not a wellness one.
Absorption competition and timing. Magnesium can interfere with the absorption of some drugs, including certain antibiotics and thyroid medication. Mechanistically clear; the practical answer is spacing, which your pharmacist can specify.
No feedback loop. Because you cannot easily confirm status, an ineffective product and an unnecessary product look identical from the inside.
Diminishing returns. If intake is already adequate, additional magnesium is excreted. Nothing accumulates in a useful way.

Why does magnesium matter physiologically at all?

Magnesium is a cofactor for a large number of ATP-dependent enzymes — ATP is functionally active as a magnesium complex — and it modulates neuromuscular excitability, partly through effects on calcium channels and NMDA receptor behaviour. That mechanism explains why genuine depletion can present as cramps, tremor, irritability and cardiac rhythm disturbance, and why correcting depletion resolves those signs.

It also explains the ceiling. A cofactor that is already present in sufficient quantity does not accelerate the reaction further. This is the single most useful idea for anyone wondering why their capsule changed nothing: the mechanism predicts benefit from repletion, not benefit from surplus.

Is the form the reason it failed?

Sometimes, but less often than the price difference implies.

Magnesium oxide (MgO) is an oxide and magnesium hydroxide (Mg(OH)₂) is a hydroxide. Neither is a salt in the strict sense — a salt is the product of neutralising an acid with a base, so its anion is an acid residue such as citrate or carbonate, not O²⁻ or OH⁻ — and both of these compounds dissolve poorly at intestinal pH. They carry a high proportion of elemental magnesium by mass and deliver a modest fraction of it. The organic-acid salts — citrate, malate, lactate — and the glycine chelate (magnesium bisglycinate, usually labelled magnesium glycinate) are more soluble compounds; they carry less magnesium per gram of compound but a larger share of it is available for absorption. That comparison is solid chemistry.

What is not established is the step marketing takes next. I have not found a trial that directly compares magnesium forms head-to-head on a symptom outcome such as sleep quality, cramp frequency or mood in the same participants. Two separate placebo comparisons do not compose into a head-to-head result, and a solubility advantage is an absorption argument, not an outcome argument. Claims that a specific branded or "liposomal" magnesium outperforms a cheap soluble salt on how you feel rest on mechanism and extrapolation, not on comparative human outcome data.

Also worth disambiguating: magnesium glycinate (a chelate of the amino acid glycine) is not magnesium gluconate (a salt of gluconic acid) — different compounds with different evidence. Magnesium stearate is a manufacturing lubricant found in capsules, not a magnesium supplement. And magnesium L-threonate is chemically the same magnesium ion attached to a different carrier; it is not a separate mineral.

What should you actually check before concluding it doesn't work?

Ranked by how strong the evidence behind each criterion is, not by how prominently it is advertised:

Do you plausibly have a deficit at all? Low habitual intake, chronic alcohol use, ongoing gastrointestinal losses, or a depleting medication. Direct human outcome evidence exists for treating documented deficiency; without a deficit, the rest of the list is moot.
Is the total elemental magnesium delivered, and tolerated, reasonable? An unabsorbed dose that produces an osmotic effect is not a delivered dose. Biomarker-supported.
Is the compound soluble? Choosing a soluble organic-acid salt or glycine chelate over the oxide is defensible. Mechanistically plausible, on absorption grounds.
Timing, splitting, and spacing from interacting medication. Mechanistically plausible.
Premium delivery claims — liposomal, patented, "high-absorption" branding. Untested for symptom outcomes against a cheap soluble form, as far as I could locate.

Verdict

If magnesium did nothing for you, the most probable reason is that you did not need it. That is a good outcome badly described. For most people with a plausible deficit, the sensible default is the cheapest well-studied soluble form, taken with food, at a dose that does not produce an osmotic effect — not an upgrade to a more expensive form, because no head-to-head human trial I could find shows that the upgrade changes symptoms. If you have reduced kidney function, or you are chasing a symptom that has persisted despite adequate intake, the next step is diagnostic rather than commercial.